For research use only. Not for therapeutic Use.
CDK2-IN-13 (Compound 15) is a CDK2 inhibitor with an IC50 of 12 µM. CDK2-IN-13 can be used in research of cancer[1].
Catalog Number | M139371 |
CAS Number | 101622-53-1 |
Synonyms | N-benzyl-2-chloro-9-methylpurin-6-amine |
Molecular Formula | C13H12ClN5 |
Purity | ≥95% |
InChI | InChI=1S/C13H12ClN5/c1-19-8-16-10-11(17-13(14)18-12(10)19)15-7-9-5-3-2-4-6-9/h2-6,8H,7H2,1H3,(H,15,17,18) |
InChIKey | QNKNBVBQFILDGJ-UHFFFAOYSA-N |
SMILES | CN1C=NC2=C(N=C(N=C21)Cl)NCC3=CC=CC=C3 |
Reference | [1]. Havlícek L, et al. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J Med Chem. 1997 Feb 14;40(4):408-12. |